Investing.com UK - Financial Markets Worldwide
Join +750K new investors every month who copy stock picks from billionaire's portfoliosSign Up Free

Why CTI BioPharma Shares Are Trading Higher By 84%; Here Are 20 Stocks Moving Premarket

Published 10/05/2023, 13:52
Updated 10/05/2023, 15:10
© Reuters. Why CTI BioPharma Shares Are Trading Higher By 84%; Here Are 20 Stocks Moving Premarket
IXIC
-

Benzinga - Gainers

  • Unique Fabricating, Inc. (NYSE: UFAB) gained 88.8% to $0.34 in pre-market trading after gaining around 4% on Tuesday.
  • CTI BioPharma Corp. (NASDAQ: CTIC) gained 84.2% to $8.88 in pre-market trading after Swedish Orphan Biovitrum AB announced plans to acquire CTI BioPharma in a transaction worth $1.7 billion.
  • Addex Therapeutics Ltd (NASDAQ: ADXN) gained 52.5% to $1.14 in pre-market trading. An Independent Interim Review Committee has recommended Addex Therapeutics' ADX71149 (JNJ-40411813) Phase 2 epilepsy study continue after reviewing unblinded data from Part 1 Of Cohort 1.
  • Upstart Holdings, Inc. (NASDAQ: UPST) surged 32.6% to $18.69 in pre-market trading after the company reported better-than-expected Q1 EPS and issued strong Q2 guidance.
  • DIRTT Environmental Solutions Ltd. (NASDAQ: DRTT) jumped 32.5% to $0.5224 in pre-market trading following Q1 results.
  • Alto Ingredients, Inc. (NASDAQ: ALTO) gained 32.4% to $2.08 in pre-market trading. Alto Ingredients recently reported better-than-expected Q1 sales.
  • ZeroFox Holdings, Inc. (NASDAQ: ZFOX) gained 22.9% to $0.9558 in pre-market trading. ZeroFox plans for releasing generative AI into its external cybersecurity platform with the preview of FoxGPT.
  • Sharps Technology, Inc. (NASDAQ: STSS) gained 20.2% to $1.17 in pre-market trading after jumping 21% on Tuesday.
  • Fujian Blue Hat Interactive Entertainment Technology Ltd. (NASDAQ: BHAT) shares climbed 16.8% to $0.9845 in pre-market trading.
  • Synlogic, Inc. (NASDAQ: SYBX) climbed 9.7% to $0.55 in pre-market trading. Synlogic announced the FDA granted orphan drug designation to SYNB1934 for the treatment of phenylketonuria.
Losers
  • SeaStar Medical Holding Corporation (NASDAQ: ICU) fell 28.3% to $1.39 in pre-market after the company issued regulatory update related to its HDE application for pediatric selective cytopheretic device.
  • Shengfeng Development Limited (NASDAQ: SFWL) fell 25% to $6.60 in pre-market trading after jumping around 99% on Tuesday.
  • Mobiquity Technologies, Inc. (NASDAQ: MOBQ) fell 22.4% to $0.2090 in pre-market trading after surging 75% on Tuesday.
  • Amplitude, Inc. (NASDAQ: AMPL) shares dropped 18.7% to $9.45 in pre-market trading following Q1 results.
  • Cuentas Inc. (NASDAQ: CUEN) shares dropped 18.5% to $5.62 in pre-market trading after climbing around 27% on Tuesday.
  • Twilio Inc. (NYSE: TWLO) fell 16.4% to $46.80 in pre-market trading after the company issued weak Q2 revenue guidance.
  • Airbnb, Inc. (NASDAQ: ABNB) fell 13.8% to $109.73 in pre-market trading after the company issued soft Q2 guidance.
  • Invitae Corporation (NYSE: NVTA) fell 12.5% to $1.41 in pre-market trading after posting Q1 results.
  • Bluejay Diagnostics, Inc. (NASDAQ: BJDX) shares fell 12.2% to $0.2501 in pre-market trading after declining over 3% on Tuesday.
  • Babylon Holdings Limited (NYSE: BBLN) fell 9.8% to $6.39 in pre-market trading after posting downbeat quarterly sales.
Now Read This: Disney Likely To Report Lower Q2 Earnings; Here's A Look At Recent Price Target Changes By The Most Accurate Analysts

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.